AXIAL SPONDYLOARTHRITIS
Clinical trials for AXIAL SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new AXIAL SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to ease back pain and stiffness for arthritis patients
Symptom relief Not yet recruitingThis study tests whether the drug vilamakitug can reduce symptoms of axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. About 150 adults with active disease will receive either the drug or a placebo. The main goal is to see if more people get at lea…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New study: can a common painkiller tame back pain in spondyloarthritis?
Symptom relief Not yet recruitingThis study looks at whether a drug called acemetacin can reduce pain and control disease activity in adults with active axial spondyloarthritis, a type of inflammatory arthritis that mainly affects the spine. About 150 people aged 18 to 65 will take a daily pill for 4 weeks. Rese…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can exercise change a key blood marker in arthritis patients?
Knowledge-focused Not yet recruitingThis study looks at how two different exercise programs—high-intensity intervals and moderate continuous activity—affect a blood marker called irisin, as well as disease activity, physical function, and quality of life in people with axial spondyloarthritis. About 75 adults with …
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC